Literature DB >> 28332236

The mortality rate of electroconvulsive therapy: a systematic review and pooled analysis.

N Tørring1,2, S N Sanghani3,4, G Petrides3,4, C H Kellner5, S D Østergaard1,2.   

Abstract

OBJECTIVE: Electroconvulsive therapy (ECT) remains underutilized because of fears of cognitive and medical risks, including the risk of death. In this study, we aimed to assess the mortality rate of ECT by means of a systematic review and pooled analysis.
METHOD: The study was conducted in adherence with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline. The ECT-related mortality rate was calculated as the total number of ECT-related deaths reported in the included studies divided by the total number of ECT treatments.
RESULTS: Fifteen studies with data from 32 countries reporting on a total of 766 180 ECT treatments met the inclusion criteria. Sixteen cases of ECT-related death were reported in the included studies yielding an ECT-related mortality rate of 2.1 per 100 000 treatments (95% CI: 1.2-3.4). In the nine studies that were published after 2001 (covering 414 747 treatments), there was only one reported ECT-related death.
CONCLUSION: The ECT-related mortality rate was estimated at 2.1 per 100 000 treatments. In comparison, a recent analysis of the mortality of general anesthesia in relation to surgical procedures reported a mortality rate of 3.4 per 100 000. Our findings document that death caused by ECT is an extremely rare event.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  electroconvulsive therapy; mood disorders; mortality; psychotic disorders; safety

Mesh:

Year:  2017        PMID: 28332236     DOI: 10.1111/acps.12721

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  14 in total

1.  Modified Anesthesia Protocol for Electroconvulsive Therapy Permits Reduction in Aerosol-Generating Bag-Mask Ventilation during the COVID-19 Pandemic.

Authors:  James Luccarelli; Claudia Fernandez-Robles; Carlos Fernandez-Robles; Ryan J Horvath; Sheri Berg; Thomas H McCoy; Stephen J Seiner; Michael E Henry
Journal:  Psychother Psychosom       Date:  2020-06-18       Impact factor: 17.659

2.  Worsening of movement disorder following treatment with electroconvulsive therapy in a patient with Huntington's disease.

Authors:  Hesitha Abeysundera; Allan Campbell; Shanthi Sarma
Journal:  BMJ Case Rep       Date:  2019-08-10

3.  Pre- and Post-Clerkship Knowledge, Perceptions, and Acceptability of Electroconvulsive Therapy (ECT) in 3rd Year Medical Students.

Authors:  Muaid Ithman; Chris O'Connell; Ayodeji Ogunleye; Suhwon Lee; Brett Chamberlain; Anupama Ramalingam
Journal:  Psychiatr Q       Date:  2018-12

4.  Electroconvulsive therapy (ECT) for moderate-severity major depression among the elderly: Data from the pride study.

Authors:  Søren D Østergaard; Maria S Speed; Charles H Kellner; Martina Mueller; Shawn M McClintock; Mustafa M Husain; Georgios Petrides; William V McCall; Sarah H Lisanby
Journal:  J Affect Disord       Date:  2020-05-23       Impact factor: 4.839

5.  Major Adverse Cardiac Events and Mortality Associated with Electroconvulsive Therapy: A Systematic Review and Meta-analysis.

Authors:  Andreas Duma; Mathias Maleczek; Basil Panjikaran; Harald Herkner; Theodore Karrison; Peter Nagele
Journal:  Anesthesiology       Date:  2019-01       Impact factor: 7.892

6.  International Consortium on the Genetics of Electroconvulsive Therapy and Severe Depressive Disorders (Gen-ECT-ic).

Authors:  Takahiro Soda; Declan M McLoughlin; Scott R Clark; Leif Oltedal; Ute Kessler; Jan Haavik; Chad Bousman; Daniel J Smith; Miquel Bioque; Caitlin C Clements; Colleen Loo; Fidel Vila-Rodriguez; Alessandra Minelli; Brian J Mickey; Roumen Milev; Anna R Docherty; Julie Langan Martin; Eric D Achtyes; Volker Arolt; Ronny Redlich; Udo Dannlowski; Narcis Cardoner; Emily Clare; Nick Craddock; Arianna Di Florio; Monika Dmitrzak-Weglarz; Liz Forty; Katherine Gordon-Smith; Mustafa Husain; Wendy M Ingram; Lisa Jones; Ian Jones; Mario Juruena; George Kirov; Mikael Landén; Daniel J Müller; Axel Nordensköld; Erik Pålsson; Meethu Paul; Agnieszka Permoda; Bartlomiej Pliszka; Jamie Rea; Klaus O Schubert; Joshua A Sonnen; Virginia Soria; Will Stageman; Akihiro Takamiya; Mikel Urretavizacaya; Stuart Watson; Maxim Zavorotny; Allan H Young; Eduard Vieta; Janusz K Rybakowski; Massimo Gennarelli; Peter P Zandi; Patrick F Sullivan; Bernhard T Baune
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-12-04       Impact factor: 5.270

7.  [Effectiveness and tolerability of electroconvulsive therapy : Influence of clinical response from the patient's point of view].

Authors:  M Belz; M Besse; L Krech; I Methfessel; D Zilles
Journal:  Nervenarzt       Date:  2018-11       Impact factor: 1.214

8.  Real-world evidence of age-independent electroconvulsive therapy efficacy: A retrospective cohort study.

Authors:  James Luccarelli; Thomas H McCoy; Stephen J Seiner; Michael E Henry
Journal:  Acta Psychiatr Scand       Date:  2021-10-25       Impact factor: 6.392

Review 9.  [Treatment against the patient's will exemplified by electroconvulsive therapy : Clinical, legal and ethical aspects].

Authors:  D Zilles; M Koller; I Methfessel; S Trost; A Simon
Journal:  Nervenarzt       Date:  2018-03       Impact factor: 1.214

10.  Duration of Treatment in Electroconvulsive Therapy Among Patients Beginning With Acute Course Right Unilateral Brief Pulse Stimuli.

Authors:  James Luccarelli; Thomas H McCoy; Alec P Shannon; Brent P Forester; Stephen J Seiner; Michael E Henry
Journal:  J ECT       Date:  2021-12-01       Impact factor: 3.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.